NANOG and familial pancreatic carcinoma: To examine how the patient-derived Q360* mutation may disrupt the tumor-suppressive role of SPOP in pancreatic cancer, we transiently upregulated expression of SPOP-WT or SPOP-Q360* in cells overexpressing NANOG.